Clinical Supply Distribution Strategy

A clinical distribution plan must be solid enough to begin planning activities, and flexible enough to adapt to inevitable changes.

A good distribution plan starts with a clear idea of what countries the trial will be held in so that decisions can be made regarding the sourcing of the product, country label requirements, whether a depot is required, and QP considerations as needed.

In adapting a distribution plan to real-time changes, clinical supply managers must have mitigation strategies, a good foundation on how to adapt IRTs as necessary, and whether drugs can be returned for reuse. 

Check out this video with Neil Fox, PCI’s Senior Clinical Supply Manager, discussing:

  • How to choose between central or decentralized sourcing
  • Practices in grouping countries for label requirements
  • Having well-defined processes in place to move inventory between sites, from depot to depot, or between countries (where possible) – and why it is never justified to move drugs purely for cost reasons


We provide a complete range of Clinical Supply services and we are committed to supporting clients at every stage of the clinical cycle, delivering best-in-class services efficiently and effectively.

Find out more about our Clinical Supply Distribution Services.

Our dedicated team of specialists will be happy to discuss any of your Clinical Supply Distribution needs. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email